Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Pregnenolone succinate
Clinical data | |
---|---|
Trade names | Panzalone, Formula 405 |
Other names | Pregnenolone hemisuccinate; Pregn-5-en-3β-ol-20-one 3β-(hydrogen succinate) |
Routes of administration |
Topical |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.022.728 |
Chemical and physical data | |
Formula | C25H36O5 |
Molar mass | 416.558 g·mol−1 |
3D model (JSmol) | |
| |
|
Pregnenolone succinate (USAN; brand names Panzalone, Formula 405; also known as pregnenolone hemisuccinate or pregn-5-en-3β-ol-20-one 3β-(hydrogen succinate)) is a synthetic pregnane steroid and an ester of pregnenolone which is described as a glucocorticoid and anti-inflammatory drug and has been patented and marketed as a topical medication in the form of a cream for the treatment of allergic, pruritic, and inflammatory dermatitis. It has also been described as a non-hormonal sterol, having neurosteroid activity, and forming a progesterone analogue via dehydrogenation.
In addition to its glucocorticoid effects, pregnenolone succinate has been found to act as a negative allosteric modulator of the GABAA receptor and a positive allosteric modulator of the NMDA receptor similarly to pregnenolone sulfate.
See also
Glucocorticoids |
|
||||
---|---|---|---|---|---|
Antiglucocorticoids |
|
||||
Synthesis modifiers | |||||
|
Ionotropic |
|
||||
---|---|---|---|---|---|
Metabotropic |
|
||||
|